Influenza News and Research

Latest Influenza News and Research

Chinese bird flu continues to spread

The H7N9 avian influenza outbreak in China is continuing to spread, although authorities believe that the large majority of those affected did not become infected via human-to-human contact.

25 Apr 2013

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

"On this 10th anniversary of China's April 2003 admission that the SARS virus had spread across that country ... Beijing finds itself once again in a terrible position via-a-vis the microbial and geopolitical worlds," Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, writes in a Foreign Policy opinion piece, noting the emergence of a new strain of bird flu, H7N9, in the country.

25 Apr 2013

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Janssen R&D Ireland today announced primary efficacy and safety results from two global Phase 3 studies demonstrating that use of the investigational protease inhibitor simeprevir (TMC435) led to sustained virologic response 12 weeks after the end of treatment (SVR12) in 80 and 81 percent, respectively, of treatment-naive genotype 1 chronic hepatitis C adult patients with compensated liver disease, including all stages of liver fibrosis, when administered once daily with pegylated interferon and ribavirin.

24 Apr 2013

Clinical data on simeprevir for treatment of hepatitis C patients to be presented at EASL meeting

Medivir AB today announces that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of genotype 1 hepatitis C patients.

23 Apr 2013

World must be better prepared for potential pandemics

"In China an influenza virus never before seen in people had, as The Economist went to press, infected at least 82 and killed 17. Meanwhile a new type of coronavirus, the family that brought severe acute respiratory syndrome (SARS), is festering in the Middle East," an editorial in the magazine states.

23 Apr 2013

Researchers decipher the underlying mechanism of antiviral drug

A long-forgotten candidate for antiviral therapy is undergoing a renaissance: Since the 1970s, the small molecule CMA has been considered a potent agent against viral infections, yet it was never approved for clinical use.

22 Apr 2013

Editorials address China's response to emergence of H7N9 bird flu strain

"The H7N9 strain contains gene sequences that make it relatively effective, for a bird virus, at infecting humans and other mammals," Bloomberg writes.

20 Apr 2013

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

In a manuscript published today in Immunity, scientists at the Baylor Institute for Immunology Research (BIIR) and the Benaroya Research Institute at Virginia Mason report the results of a comparative study of the molecular immune responses to influenza and pneumococcal vaccines.

19 Apr 2013

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Inovio Pharmaceuticals, Inc. announced today that its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.

19 Apr 2013

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza.

19 Apr 2013

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

Sinovac Biotech Ltd., a leading provider of vaccines in China, announced today that Fengcai Zhu, Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, presented data regarding Sinovac's proprietary enterovirus 71 ("EV71") vaccine against hand, foot and mouth disease at the 13th Annual World Vaccine Congress & Expo, taking place from April 16-18, 2013, in Washington D.C.

19 Apr 2013

New assays are effective in managing patients with influenza virus infection

Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly.

18 Apr 2013

H7N9 virus continues to spread; International research team traveling to China to assist

"Two more people in China have died from a new strain of avian influenza, bringing to 16 the number of deaths from the H7N9 virus, and the government has warned that the number of infections could rise," Reuters reports.

18 Apr 2013

Findings hold promise for development of therapies to fight different viral infections

The human body has the ability to ward off viruses by activating a naturally occurring protein at the cellular level, setting off a chain reaction that disrupts the levels of cholesterol required in cell membranes to enable viruses to enter cells.

18 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

A new study concludes that approximately half of the prescriptions of Tamiflu during the 2009-10 influenza pandemic went unused in England.

18 Apr 2013

Flunisyn Phase 2a trial data shows positive results in elderly population

Following the widely publicised US Centers for Disease Control and Prevention report in February that the current season's flu vaccine is only 9% effective in the over-65 population, Immune Targeting Systems Limited, today announces positive data from a Phase 2a trial with the Company's lead pan-strain influenza A T-cell vaccine, Flunisyn, in the elderly population.

17 Apr 2013

Influenza News and Research

Latest Influenza News and Research

Chinese bird flu continues to spread

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

Janssen announces safety results from two Phase 3 studies of simeprevir in hepatitis C patients

Clinical data on simeprevir for treatment of hepatitis C patients to be presented at EASL meeting

World must be better prepared for potential pandemics

Researchers decipher the underlying mechanism of antiviral drug

Editorials address China's response to emergence of H7N9 bird flu strain

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Clinical data of EV71 vaccine for prevention of HFMD presented at World Vaccine Congress & Expo

New assays are effective in managing patients with influenza virus infection

H7N9 virus continues to spread; International research team traveling to China to assist

Findings hold promise for development of therapies to fight different viral infections

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Flunisyn Phase 2a trial data shows positive results in elderly population

Reports of H7N9 cases, deaths continue from across China

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

U.S., Chinese researchers developing vaccine for H7N9 avian flu virus; Some question speed of case reporting

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Influenza News and Research

Latest Influenza News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in